title: Basic strategy for avoiding drug interaction during stage of drug development; proposals relative to planning of non-clinical and clinical studies and how clinical trials should be planned.
authors.affiliation: Tsukuba Research Loboratories, Eisai Co., Ltd., Ibaraki, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Horie
authors.forename: H
authors.initials: H
authors.lastname: Nakata
authors.forename: K
authors.initials: K
authors.lastname: Kusube
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods*; D015195:Drug Design; D004341:Drug Evaluation / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008969:Molecular Sequence Data